View Financial HealthValiantLtd 배당 및 자사주 매입배당 기준 점검 4/6ValiantLtd 수익으로 충분히 충당되는 현재 수익률 0.72% 보유한 배당금 지급 회사입니다.핵심 정보0.7%배당 수익률0.9%자사주 매입 수익률총 주주 수익률1.6%미래 배당 수익률1.3%배당 성장률5.3%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향39%최근 배당 및 자사주 매입 업데이트공시 • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.공시 • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.모든 업데이트 보기Recent updatesBoard Change • May 20High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Lianbo Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025공시 • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025공시 • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.089 (vs CN¥0.20 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings.Buy Or Sell Opportunity • Oct 16Now 20% undervaluedOver the last 90 days, the stock has risen 6.1% to CN¥9.71. The fair value is estimated to be CN¥12.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.15 per share.Reported Earnings • Aug 22Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.공시 • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.공시 • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong ChinaReported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공시 • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.공시 • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.공시 • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.29 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.공시 • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.공시 • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 21Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.19 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.14 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 29Full year 2021 earnings released: EPS: CN¥0.69 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.Buying Opportunity • Feb 12Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Buying Opportunity • Jan 26Now 21% undervaluedOver the last 90 days, the stock is up 1.6%. The fair value is estimated to be CN¥26.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 173% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.03 per share.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.58 per share.Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥21.52, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 169% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.14 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥786.7m (up 18% from 1Q 2020). Net income: CN¥131.8m (up 6.1% from 1Q 2020). Profit margin: 17% (down from 19% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.56 (vs CN¥0.56 in FY 2019)The company reported a solid full year result with improved revenues, although earnings and profit margins were flat. Full year 2020 results: Revenue: CN¥2.92b (up 1.7% from FY 2019). Net income: CN¥504.7m (flat on FY 2019). Profit margin: 17% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 14% per year.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥17.10, the stock is trading at a trailing P/E ratio of 31.7x, down from the previous P/E ratio of 37.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 60%.Is New 90 Day High Low • Mar 06New 90-day low: CN¥18.68The company is down 6.0% from its price of CN¥19.95 on 04 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.16 per share.Is New 90 Day High Low • Jan 25New 90-day high: CN¥24.71The company is up 36% from its price of CN¥18.17 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.14 per share.Is New 90 Day High Low • Jan 07New 90-day high: CN¥22.27The company is up 18% from its price of CN¥18.89 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.89 per share.Is New 90 Day High Low • Dec 21New 90-day high: CN¥21.29The company is up 13% from its price of CN¥18.82 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.46 per share.Is New 90 Day High Low • Dec 03New 90-day high: CN¥20.51The company is up 10.0% from its price of CN¥18.66 on 04 September 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.08 per share.Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥488.8m, down 3.1% from the prior year. Total revenue was CN¥2.88b over the last 12 months, up 5.5% from the prior year.Is New 90 Day High Low • Oct 23New 90-day low: CN¥16.38The company is down 1.0% from its price of CN¥16.55 on 24 July 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥26.87 per share.공시 • Oct 17Valiant Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Valiant Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020공시 • Jul 18Valiant Co.,Ltd to Report First Half, 2020 Results on Aug 15, 2020Valiant Co.,Ltd announced that they will report first half, 2020 results on Aug 15, 2020지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 002643 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: 002643 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장ValiantLtd 배당 수익률 vs 시장002643의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (002643)0.7%시장 하위 25% (CN)0.4%시장 상위 25% (CN)1.9%업계 평균 (Chemicals)1.3%분석가 예측 (002643) (최대 3년)1.3%주목할만한 배당금: 002643 의 배당금( 0.72% )은 CN 시장에서 배당금 지급자의 하위 25%( 0.37% )보다 높습니다.고배당: 002643 의 배당금( 0.72% )은 CN 시장에서 배당금 지급자의 상위 25%( 1.95% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 39.1% )로 002643 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 합리적으로 낮은 현금 지급 비율 ( 25.9% )로 002643 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 18:16종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Valiant Co.,Ltd는 11명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xiongwei JiaChina International Capital Corporation LimitedChao LiCitic Securities Co., Ltd.Nai Di ZhaoEverbright Securities Co. Ltd.8명의 분석가 더 보기
공시 • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.
Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.
공시 • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.
Board Change • May 20High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Lianbo Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026
공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026
공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025
공시 • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025
공시 • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.
공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025
공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025
Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.
Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.089 (vs CN¥0.20 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings.
Buy Or Sell Opportunity • Oct 16Now 20% undervaluedOver the last 90 days, the stock has risen 6.1% to CN¥9.71. The fair value is estimated to be CN¥12.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.
공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.15 per share.
Reported Earnings • Aug 22Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
공시 • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024
Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.
공시 • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공시 • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.
공시 • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
공시 • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.
Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.29 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.
Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
공시 • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023
Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
공시 • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.
Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.
Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.
Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 21Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.19 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.
Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.14 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.
Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 29Full year 2021 earnings released: EPS: CN¥0.69 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.
Buying Opportunity • Feb 12Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Buying Opportunity • Jan 26Now 21% undervaluedOver the last 90 days, the stock is up 1.6%. The fair value is estimated to be CN¥26.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 173% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.03 per share.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.58 per share.
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥21.52, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 169% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.
Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.14 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥786.7m (up 18% from 1Q 2020). Net income: CN¥131.8m (up 6.1% from 1Q 2020). Profit margin: 17% (down from 19% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.56 (vs CN¥0.56 in FY 2019)The company reported a solid full year result with improved revenues, although earnings and profit margins were flat. Full year 2020 results: Revenue: CN¥2.92b (up 1.7% from FY 2019). Net income: CN¥504.7m (flat on FY 2019). Profit margin: 17% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 14% per year.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥17.10, the stock is trading at a trailing P/E ratio of 31.7x, down from the previous P/E ratio of 37.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 60%.
Is New 90 Day High Low • Mar 06New 90-day low: CN¥18.68The company is down 6.0% from its price of CN¥19.95 on 04 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.16 per share.
Is New 90 Day High Low • Jan 25New 90-day high: CN¥24.71The company is up 36% from its price of CN¥18.17 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.14 per share.
Is New 90 Day High Low • Jan 07New 90-day high: CN¥22.27The company is up 18% from its price of CN¥18.89 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.89 per share.
Is New 90 Day High Low • Dec 21New 90-day high: CN¥21.29The company is up 13% from its price of CN¥18.82 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.46 per share.
Is New 90 Day High Low • Dec 03New 90-day high: CN¥20.51The company is up 10.0% from its price of CN¥18.66 on 04 September 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.08 per share.
Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥488.8m, down 3.1% from the prior year. Total revenue was CN¥2.88b over the last 12 months, up 5.5% from the prior year.
Is New 90 Day High Low • Oct 23New 90-day low: CN¥16.38The company is down 1.0% from its price of CN¥16.55 on 24 July 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥26.87 per share.
공시 • Oct 17Valiant Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Valiant Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020
공시 • Jul 18Valiant Co.,Ltd to Report First Half, 2020 Results on Aug 15, 2020Valiant Co.,Ltd announced that they will report first half, 2020 results on Aug 15, 2020